The poster child of the AI rally has been 
NVDA and $AVGO. Here we have analysed both the stocks multiple times fundamentally and technically. But the lesser known 
AVGO has performed better than the NVDA since the April lows. AVGO is still above its previous ATH and closed above yesterday which was 242 $ in Jan 2025. NVDA is still below its Jan 2025 highs of 152 $.
The Semis index
SMH is also 6.3% below its ATH of 262 $. So not many stocks in this index have a more bullish chart than $AVGO. My assessment is that AVGO will continue its dominant outperformance in the SMH sector in comparison to others like $NVDA.
Going back to technical and plotting the Fib Extension levels form the last bull run before Aug 2024 we can see that the next possible near-term target is 275 $, a 10% upside form here and in the medium term the target is 400 $.
Verdict : LongAVGO over SMH and $NVDA. First Target 275 $ then we go to 400 $.
NVDA and $AVGO. Here we have analysed both the stocks multiple times fundamentally and technically. But the lesser known AVGO has performed better than the NVDA since the April lows. AVGO is still above its previous ATH and closed above yesterday which was 242 $ in Jan 2025. NVDA is still below its Jan 2025 highs of 152 $.The Semis index
SMH is also 6.3% below its ATH of 262 $. So not many stocks in this index have a more bullish chart than $AVGO. My assessment is that AVGO will continue its dominant outperformance in the SMH sector in comparison to others like $NVDA. Going back to technical and plotting the Fib Extension levels form the last bull run before Aug 2024 we can see that the next possible near-term target is 275 $, a 10% upside form here and in the medium term the target is 400 $.
Verdict : Long
AVGO over SMH and $NVDA. First Target 275 $ then we go to 400 $.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.